Surgical Resection Followed by Adjuvant Therapy
For this 68-year-old patient with extensive operable tongue recurrence and post-radiation trismus, proceed with surgical resection using specialized techniques to manage the trismus, followed by risk-adapted adjuvant therapy based on pathologic findings.
Surgical Approach
The primary treatment for operable oral cavity recurrence after prior radiotherapy is surgical resection 1. The EHNS-ESMO-ESTRO guidelines explicitly state that primary surgical treatment is recommended for T3/T4 oral cavity cancers 1. This applies to your recurrent disease, as oral cavity tumors—including tongue—are best managed surgically when resectable.
Managing the Trismus Challenge
The post-radiation trismus creates a technical challenge but does not preclude surgery:
Transoral robotic surgery (TORS) is highly effective for tongue cancers with trismus. A 2025 study demonstrated 98.5% negative margin rates in 67 patients, with successful completion in all trismus cases without conversion to open surgery 2. TORS may actually improve mouth opening through release of fibrotic tissue during the procedure.
Lingual sulcus release technique provides an additional safe margin layer when accessing tongue tumors with trismus, offering a reproducible transcervical approach 3.
Traditional open approaches with mandibular swing or pull-through techniques remain options if transoral access is inadequate, though they carry higher morbidity 1.
The key surgical principle: achieving negative margins is the only surgeon-controlled prognostic factor 3. Do not compromise on margin adequacy due to access limitations.
Reconstruction Requirements
Wide surgical excision requires appropriate reconstruction 1:
- Free vascularized soft tissue flap (radial forearm or anterolateral thigh) when mandibular continuity is intact
- Bony flap (fibula) if mandibular resection is needed
- Consider hyoid suspension to the mandible to optimize postoperative swallowing function 4
Adjuvant Therapy Decision Algorithm
Post-resection pathology dictates adjuvant treatment 1:
Postoperative RT Indications:
- pT3-4 tumors
- Perineural infiltration
- Lymphatic infiltration
1 invaded lymph node
- Extracapsular infiltration
Postoperative CRT (Chemoradiation) Indications:
- R1 resection (positive microscopic margins)
- Extracapsular rupture
Critical timing: Initiate postoperative RT or CRT within 6-7 weeks of surgery 1.
For chemotherapy, use cisplatin 100 mg/m² on days 1,22, and 43 of concurrent RT (70 Gy) 1. If the patient is unfit for cisplatin, alternatives include carboplatin combined with 5-FU or cetuximab with RT 1.
Important Caveats
Trismus release procedures alone (without tumor resection) show modest long-term results with high recurrence rates, particularly after prior buccal resection or maxillectomy 5. Mean long-term gain is only 8.9 mm, with significant postoperative loss. These are not appropriate as primary treatment for the tumor itself—only as adjunctive procedures during oncologic resection.
Re-irradiation considerations: This patient has already received RT. While the guidelines support postoperative RT/CRT after salvage surgery 1, the radiation oncology team must carefully assess cumulative dose constraints to critical structures. The prior RT does not contraindicate surgery but does increase surgical complexity and wound healing risks.
Multidisciplinary discussion at a high-volume facility is essential 1. The surgical approach, reconstruction plan, and adjuvant therapy must be coordinated before proceeding.